Regenexx Australia offers dextrose prolotherapy: a treatment that can help minimise the effects of injuries to ligaments and tendons. Some patients with joint damage might also benefit from prolotherapy treatment.
Dextrose prolotherapy is the injection of a concentrated Dextrose solution mixed with a potent local anaesthetic directly into the damaged tissue.
The Dextrose solution is manufactured under sterile conditions specifically for administration by injection.
Independent clinical data supports the use of dextrose prolotherapy in the treatment of tennis elbow and rotator cuff injuries. Positive results have also been seen when treating plantar fasciitis and low back pain arising from the sacroiliac joint.
Dextrose prolotherapy has also been shown to reduce knee pain due to osteoarthritis in specific populations, with some researchers suggesting it is as effective as exercise at reducing the pain of osteoarthritis[6,7].
Dextrose prolotherapy forms part of a total treatment program including activity modification and a good diet.
Dextrose Prolotherapy is an “off-the-shelf” treatment that can be provided as part of a booked consultation. No preparation is required.
Soft tissue injuries are usually treated with a course of 4 to 5 injections given 3 to 4 weeks apart. If patients have not responded after 3 injections they are unlikely to respond at all. Most patients do not benefit from having more than 7 injections in a series.
Large joints, such as the knee, are often treated with repeated injections of prolotherapy given about 1 month apart. Smaller joints such as finger joints often only require injections every 3 to 6 months.
You don't have to live with an injury or pain. Contact us to find out if prolotherapy is suitable for your condition.
Hypertonic dextrose and morrhuate sodium injections (prolotherapy) for lateral epicondylosis (tennis elbow): results of a single-blind, pilot-level, randomized controlled trial. Rabago D, Lee KS, Ryan M, Chourasia AO, Sesto ME, Zgierska A, Kijowski R, Grettie J, Wilson J, Miller D. Am J Phys Med Rehabil. 2013 Jul;92(7):587-96. doi: 10.1097/PHM.0b013e31827d695f. PMID: 23291605; PMCID: PMC3700532.
A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain. Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. Clin Med Insights Arthritis Musculoskelet Disord. 2016 Jul 7;9:139-59. doi: 10.4137/CMAMD.S39160. PMID: 27429562; PMCID: PMC4938120.
Effect of Dextrose Prolotherapy on Pain Intensity, Disability, and Plantar Fascia Thickness in Unilateral Plantar Fasciitis: A Randomized, Controlled, Double-Blind Study. Mansiz-Kaplan B, Nacir B, Pervane-Vural S, Duyur-Cakit B, Genc H. Am J Phys Med Rehabil. 2020 Apr;99(4):318-324. doi: 10.1097/PHM.0000000000001330. PMID: 31738283.
Functional outcome from sacroiliac joint prolotherapy in patients with sacroiliac joint instability. Hoffman MD, Agnish V. Complement Ther Med. 2018 Apr;37:64-68. doi: 10.1016/j.ctim.2018.01.014. Epub 2018 Feb 8. PMID: 29609940.
Efficacy of intra-articular hypertonic dextrose prolotherapy versus normal saline for knee osteoarthritis: a protocol for a triple-blinded randomized controlled trial. Sit RWS, Wu RWK, Reeves KD, Rabago D, Chan DCC, Yip BHK, Chung VCH, Wong SYS.BMC Complement Altern Med. 2018 May 15;18(1):157. doi: 10.1186/s12906-018-2226-5. PMID: 29764447; PMCID: PMC5952445.
The effectiveness of prolotherapy in treating knee osteoarthritis in adults: a systematic review. Hassan F, Trebinjac S, Murrell WD, Maffulli N. Br Med Bull. 2017 Jun 1;122(1):91-108. doi: 10.1093/bmb/ldx006. PMID: 28334196.
The Effects of Dextrose Prolotherapy in Symptomatic Knee Osteoarthritis: A Randomized Controlled Study. Sert AT, Sen EI, Esmaeilzadeh S, Ozcan E. J Altern Complement Med. 2020 May;26(5):409-417. doi: 10.1089/acm.2019.0335. Epub 2020 Mar 30. PMID: 32223554.